Publications

Does depression treatment improve the survival of depressed cancer patients? A long-term follow-up of participants in the SMaRT Oncology-2 and 3 trials.
12 Mar 2018 in Lancet Psychiatry
DOI: https://doi.org/10.1016/S2215-0366(18)30061-0
Contribution to journal › Article (Published)

Is improvement in comorbid major depression associated with longer survival in people with cancer? A long-term follow-up of participants in the SMaRT oncology-2 and 3 trials
14 Nov 2018 in Journal of Psychosomatic Research
DOI: https://doi.org/10.1016/j.jpsychores.2018.11.008
Contribution to journal › Article (Published)

1211TiPFAK-PD1: a phase I/IIa trial of FAK (defactinib) & PD-1 (pembrolizumab) inhibition
1 Sep 2017 in Annals of oncology, vol. 28
DOI: https://doi.org/10.1093/annonc/mdx376.071
Contribution to journal › Meeting abstract (Published)

FAK-inhibition opens the door to checkpoint immunotherapy in Pancreatic Cancer
21 Feb 2017 in Journal for immunotherapy of cancer, vol. 5, pp. 17
DOI: https://doi.org/10.1186/s40425-017-0217-6
Contribution to journal › Article (Published)

Continual reassessment method for dose escalation clinical trials in oncology : A comparison of prior skeleton approaches using AZD3514 data
31 Aug 2016 in BMC Cancer, vol. 16
DOI: https://doi.org/10.1186/s12885-016-2702-6
Contribution to journal › Article (Published)

View all 12 publications on Research Explorer

Data last updated: 15/11/2019 at 11:30